Sharing-our-perspective-page-header2

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward



  • WCRC contractor transition webinar held with The Centers for Medicare and Medicaid Services

    by
    • MSCC
    • Donna Mize
    | May 15, 2019
    Tag Icon
    WCRC, Workers' Compensation, Medicare Insights
    The Centers for Medicare and Medicaid Services (CMS) held a webinar on March 7, 2018, to introduce Capitol Bridge, LLC, our new WCRC contractor, and review the transition plan. John Jenkins of CMS and Holly Havens of Capitol Bridge discussed the transition between the two WCRC contractors—the incumbent, Provider Resources, LLC, and Capitol Bridge. The last day for Provider Resources will be March 16, 2018, with Capitol Bridge beginning March 19, 2018. The transition will occur over the weekend and should not disrupt business or cause a backlog.


  • Important change regarding Medicaid secondary payer claim compliance

    by
    | May 15, 2019
    Tag Icon
    Medicare Secondary Payer, Medicare Insights, Settlement Solutions
    On February 9, 2018 President Trump signed into law a new budget deal. The new law also contained an important change regarding Medicaid Secondary Payer compliance. What Optum had been anticipating Optum Settlement Solutions had been anticipating an Oct 1, 2017 effective date for state Medicaid agencies to begin enforcing the Medicaid Secondary Payer Act enacted in Section 202(b) of the Bipartisan Budget Agreement of 2013, referred to as the “Murray-Ryan bill”. The act permitted state Medicaid agencies to recover all payments Medicaid made related to the underlying personal injury claim before settlement. The recovery was to occur regardless of whether the damages/injuries claimed were related to the medical component of damages within a personal injury settlement or third party settlement.


  • CMS Releases NGHP Section 111 User Guide v5.3

    by
    • Donna Mize
    | May 15, 2019
    Tag Icon
    Medicare Insights, Settlement Solutions, CMS
    CMS has released an updated NGHP User Guide, version number 5.3. The updates address the new Medicare Beneficiary Identifier (MBI) initiative in the Introduction, Overview and Appendices chapters.


  • Our Industry Trends Report is now available

    by
    • Optum Workers' Comp
    | May 06, 2019
    Tag Icon
    Analytics, Ancillary, Drug Formulary, Medicare Set-Aside, Opioids, Optum Workers Comp Auto No Fault, Predictive Analytics, Settlement Solutions, Workers' Compensation
    A 2018 REVIEW OF THE PREVAILING INDUSTRY INFLUENCES IMPACTING CLAIM OUTCOMES


  • FDA approves the first generic naloxone nasal spray to treat opioid overdoses

    by
    • Optum for Workers' Compensation
    | Apr 29, 2019
    Tag Icon
    FDA approved, Clinical, Opioids, Narcan
    On April 19, the U.S. Food and Drug Administration (FDA) approved the first generic for Narcan® Nasal Spray, the life-saving medication used for the emergency treatment of opioid-related overdose.


  • Medication Recall: Two lots of fentanyl transdermal system (patch) recalled

    by
    • Optum for Workers' Compensation
    | Apr 25, 2019
    Tag Icon
    recall, Opioids, Fentanyl, Clinical, FDA
    The U.S. Food and Drug Administration (FDA) announced that Alvogen, Inc. voluntarily recalled two lots of fentanyl patches 12 mcg/hour at the consumer level.


  • FDA requires label changes for opioid analgesics to guide prescribers when gradual tapering is needed

    by
    • Optum Workers' Comp
    | Apr 15, 2019
    Tag Icon
    FDA, Pharmacy, Opioids, opioid analgesics, Clinical
    The U.S. Food and Drug Administration (FDA) issued a safety communication in early April that requires changes to prescribing information for opioid analgesics used in outpatient settings. The goal is to expand the information available to health care providers and patients when opioid analgesics have been prescribed and there is a need to safely decrease the dose or discontinue use of an opioid analgesic



Stay informed by receiving latest updates

Do you have a question about a blog post?

See more insights